FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/08/020756 [Registered on: 19/08/2019] Trial Registered Retrospectively
Last Modified On: 16/08/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   Exploring the role of Lasunadaya Ghrita pana and nasya in primary depression:A non randomized open clinical study. 
Scientific Title of Study   "Exploring the role of Lasunadya Ghrita Pana & Nasya in case of Primary Depression:A non randomized open clinical study". 
Trial Acronym  LGPD 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  vandana tiwari 
Designation  MD SCHOLAR  
Affiliation  STATE AYURVEDIC COLLEGE LUCKNOW 
Address  DEPARTMENT OF KAYACHIKITSHA STATE AYURVEDIC COLLEGE LUCKNOW
DEPARTMENT OF KAYACHIKITSHA STATE AYURVEDIC COLLEGE LUCKNOW
Lucknow
UTTAR PRADESH
226003
India 
Phone  9140808264  
Fax    
Email  vandana.tiwari125@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sanjeev Rastogi 
Designation  Reader (MD PHD)  
Affiliation  STATE AYURVEDIC COLLEGE LUCKNOW 
Address  DEPARTMENT OF KAYACHIKITSHA STATE AYURVEDIC COLLEGE LUCKNOW

Lucknow
UTTAR PRADESH
226003
India 
Phone  9415022955  
Fax    
Email  rastogisanjeev@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  vandana tiwari 
Designation  MD SCHOLAR  
Affiliation  STATE AYURVEDIC COLLEGE LUCKNOW 
Address  DEPARTMENT OF KAYACHIKITSHA STATE AYURVEDIC COLLEGE LUCKNOW
DEPARTMENT OF KAYACHIKITSHA STATE AYURVEDIC COLLEGE LUCKNOW
Lucknow
UTTAR PRADESH
226003
India 
Phone  9140808264  
Fax    
Email  vandana.tiwari125@gmail.com  
 
Source of Monetary or Material Support  
Drug formation is done by me with the help of a local pharmacy. 
Literary review is taken with the help of Institutional library. 
 
Primary Sponsor  
Name  Self 
Address  DEPARTMENT OF KAYACHIKITSHA STATE AYURVEDIC COLLEGE LUCKNOW 
Type of Sponsor  Other [Individual] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vandana Tiwari  State ayurvedic college lucknow and kgmu lucknow  Department of kayachikitsha state ayurvedic college lucknow
Lucknow
UTTAR PRADESH 
9140808264

vandana.tiwari125@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Conditional approval by Institutional Ethics Committee was given on 29/10/17 which is six month before enrolment of first patient. So please consider this  Approved 
Institutional Ethics Committee State Ayurvedic College Lucknow  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F321||Major depressive disorder, singleepisode, moderate, primary depression,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  ESCITALOPRAM  Dose:- 10mg HS, if patient having insomnia Zoltidem 10 to 20 mg HS, If patient having anxiety as pre-dominant symptom then etizolam .25 to 2mg HS Duration: 28 days Route of administration: Oral 
Intervention  LASUNADYA GHRITA  DOSE- 5 gram in two divided doses with warm milk Duration: 28 days Route of administration: Oral & Nasal Instillation. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient diagnosed as primary depression as per ICD-10 criteria.patient having depression for not more than two years.patients willing to participate in the study voluntarily giving their informed consent.patient not having any other physical and mental co-morbidity considered as contraindication to the treatment. 
 
ExclusionCriteria 
Details  Patient below 20 years and over 60 years.Patients having any other psychiatric co-morbidity.Patient having cognitive malfunctions due to substance abuse or due to age related dementia or mental retardation.Females in the stage of pregnancy or lactation.Patients having suicidal ideation or history of attempted suicide.Patients with marked irritable,unstable and violent behaviour.Patients allergic to any component of medication.Patients unable to take lasun or go-mutra due to their personal customs or belief.Patients not giving the consent for the study.Any condition where nasya is contraindicated. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in Hamilton Depression Scale  Base line and 4 week 
 
Secondary Outcome  
Outcome  TimePoints 
SF-36  Base line and Week 4 
 
Target Sample Size   Total Sample Size="72"
Sample Size from India="72" 
Final Enrollment numbers achieved (Total)= "56"
Final Enrollment numbers achieved (India)="56" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   16/04/2018 
Date of Study Completion (India) 06/05/2019 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="0"
Days="28" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Mental health is given foremost importance in ayurveda.Depression as a disease has many peculiarties.It may begin early at the age,may have multifaceted causes of which many may belong to the life style stressors,may results in huge personal, interpersonal, social and economical losses and may end up in suicidal attempts.It is in this purview,we are proposing to sceen Lasunadya ghrita for its therapeutic potential in cases of primary depression.Lasunadya ghrita is identified as a potential drug to unmad, a mental condition refered in ayurveda and having some resemblance to depression in context to it’s kaphaj subtype. Lasunadya ghrita is recommended to be used in such cases as an oral medication as well as in the form  of instillation.For the purpose of present study we propose to have an enhanced effect on depression.The study is proposed to be non randomized open clinical trial having comparison of ayurvedic protocol with that of current psychiatric protocol.This clinical trial consisting of two groups namely interventional group and active comparator group.Intervention group is proposed to be given lasunadya ghrita nasya for 20 sitting comprising of approximately 5 sitting in a week.In addition to nasya this group is also recommended for lasunadya ghrita pana in a dose of 5 gram in a day in two divided with warm milk before meal for 4 weeks.Active comparator group is proposed to be given conventional pharmacotherapy for depression (Escitalopram 10 mg HS) as recommended by department of psychiatry kgmu Lucknow.In the study the total sample is considered to be 72 with approximate 36 sample in each group.For outcome assessment a significant reduction in HAMD score (less than 7) will be considered as remission to an individual patient. 
Close